Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase

Blood

Volumn 92, Issue 9, 1998, Pages 3050-3056

  Kruyt, Frank A E ^b   Hoshino, Taizo ^b   Liu, Johnson M ^b   Joseph, Pius ^b   Jaiswal, Anil K ^b   Youssoufian, Hagop ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE; CELL PROTEIN; FLAVINE MONONUCLEOTIDE; MITOMYCIN C; PROTEIN FAC; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DETOXIFICATION; FANCONI ANEMIA; IMMUNOBLOTTING; LIVER CELL; MICROSOME MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0032213353     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3050.421k56_3050_3056     Document Type: Article

References (51)

1. Fanconi G: Familial panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol 4:233, 1967
2. D'Andrea AD, Grompe M: Molecular biology of Fanconi anemia: Implications for diagnosis and therapy. Blood 90:1725, 1997
3. Strathdee CA, Duncan AMV, Buchwald M: Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1:196, 1992
4. Buchwald M: Complementation groups: One or more per gene? Nat Genet 11:228, 1995
5. Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F: Evidence for at least eight Fanconi anemia groups. Am J Hum Genet 61:940, 1997
6. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992 (Correction: Nature 358:434, 1993)
7. Strathdee CA, Gavish H, Shannon WR, Buchwald M: Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 356:763, 1992 (Correction: Nature 358:434, 1993)
8. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alon N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CGM, Strunk MHP, Gille JJP, Pals G, Kruyt FAE, Pronk JC, Arwert F, Buchwald M, Joenje H: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 14:320, 1996
9. Pronk JC, Gibson RA, Savoia A, Wijker M, Morgan NV, Melchionda S, Ford D, Temtamy S, Ortega JJ, Jansen S, Havenga C, Cohn RJ, de Ravel TJ, Roberts I, Westerveld A, Easton DF, Joenje H, Mathew CG, Arwert F: Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet 11:338, 1995
10. Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach R, Naylor S, Joenje H, Grompe M: Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene on chromosome 3p. Nat Genet 11:341, 1995
11. The Fanconi Anaemia/Breast Cancer Consortium: Positional cloning of the Fanconi anaemia group A gene. Nat Genet 14:324, 1996
12. Mian IS, Moser MJ: The Fanconi anemia complementation group A protein contains a peroxidase domain. Molec Genet Metab 63:230, 1998
13. Kruyt FAE, Waisfisz Q, Dijkmans LM, Hermsen MAJA, Youssoufian H, Arwert F, Joenje H: Cytoplasmic localization of a functionally active fanconi anemia group A-green fluorescent protein chimera in human 293 cells. Blood 90:3288, 1997
14. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD: The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex, Nat Genet 17:487, 1997
15. Kruyt FAE, Youssoufian H: The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity. Blood 92:2229, 1998
16. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD: The Fanconi anemia polypeptide, FACC, is localized to the cytoplasm. Proc Natl Acad Sci USA 91:6712, 1994
17. Youssoufian H: Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 91:7975, 1994
18. Youssoufian H, Auerbach AD, Verlander PC, Steimle V, Mach B: Identification of cytosolic proteins that bind to the Fanconi anemía complementation group C polypeptide in vitro. J Biol Chem 270:9876, 1995
19. Youssoufian H: Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi Anemia group C cells. J Clin Invest 97:2003, 1996
20. Hoatlin ME, Christianson TA, Keeble WW, Hammond AT, Zhi Y, Heinrich MC, Tower PA, Bagby GC: The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood 91:1418, 1998
21. Setlow RB: Repair deficient human disorders and cancer. Nature 271:713, 1978
22. Gale EF, Cundliffe E, Reynolds PE, Richmond MH, Waring MJ, in: The Molecular Basis of Antibiotic Action (ed 2). London, UK, Wiley, 1981, p 353
23. Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB: Oxygen dependence of chromosomal aberrations in Fanconi's anemia. Nature 290:142, 1981
24. Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G, Gandini E: Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes. Hum Genet 69:62, 1985
25. Saito H, Hammond AT, Moses RE: Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat Res 294:255, 1993
26. Youssoufian H, Li Y, Martin ME, Buchwald M: Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele. J Clin Invest 97:957, 1996
27. Ross D, Siegel D, Beall H, Prakash AS, Mulcahy RT, Gibson NW: DT-deaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Met Rev 12:83, 1993
28. Pan SS, Andrews PA, Glover CJ, Bachur NR: Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 259:959, 1984
29. Bligh HF, Bartoszek A, Robson CN, Hickson ID, Kasper CB, Beggs JD, Wolf CR: Activation of mitomycin C by NADPH: cytochrome P450 reductase. Cancer Res 50:7789, 1990
30. Porter TD, Kasper CB: Coding nucleotide sequence of rat NADPH-cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding domains. Proc Natl Acad Sci USA 82:973, 1985
31. Porter TD, Kasper CB: NADPH-cytochrome P-450 oxidoreductase: Flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins. Biochemistry 25:1682, 1986
32. Smith GCM, Tew DG, Wolf CR: Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. Proc Natl Acad Sci USA 91:8710, 1994
33. Fisher CW, Shet MS, Caudle DL, Martin-Wixtrom CA, Estabrook RW: High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. Proc Natl Acad Sci USA 89:10817, 1992
34. Belcourt MF, Hodnick WF, Rockwell S, Sartorelli AC: Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.Proc Natl Acad Sci USA 93:456, 1996
35. Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID: Decreased NADPH:cytochrome P450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res 50:4692, 1990
36. Youssoufian H: Immunoaffinity purification of antibodies against GST fusion proteins. BioTechniques 24:198, 1998
37. Li Y, Youssoufian H: MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups. J Clin Invest 100:2873, 1997
38. Fields S, Song O: A novel genetic system to detect protein-protein interactions. Nature 340:245, 1989
39. Joseph P, Jaiswal AK: NAD(P)H:Quinone oxidoreduxtase 1 (DT diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 91:8413, 1994
40. Joseph P, Xu Y, Jaiswal AK: Non-enzymatic and enzymatic activation of mitomycin C: Identification of a unique cytosolic activity. Int J Cancer 65:263, 1996
41. Chen M, Tomkins DJ, Auerbach W, McKerlie C, Youssoufian H, Liu L, Can O, Carreau M, Auerbach A, Groves T, Guidos CJ, Freedman MH, Cross J, Percy DH, Dick JE, Joyner AL, Buchwald M: Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genet 12:448, 1996
42. Blake JAR, Pritchard M, Ding S, Smith GCM, Burchell B, Wolf CR, Friedberg T: Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli. FEBS Lett 397:210, 1996
43. Parikh A, Gillam EMJ, Guengerich FP: Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol 15:784, 1997
44. Takeuchi T, Morimoto K: Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 14:1115, 1993
45. Degan P, Bonassi S, De Caterina M, Korkina LG, Pinto L, Scopacasa F, Zatterale A, Calzone R, Pagano G: In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16:735, 1995
46. Clarke AA, Philpott NJ, Gordon-Smith EC, Rutherford TR: The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 96:240, 1997
47. Seaton MJ, Follansbee MH, Bond JA: Oxidation of 1,2-epoxy-3-butene to l,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16:2287, 1995
48. Boogaard PJ, Bond JA: The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol Appl Pharmacol 141:617, 1996
49. Krause RJ, Elfarra AA: Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: Evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch Biochem Biophys 337:176, 1997
50. Hoshino T, Wang J, Devetten MP, Iwata N, Kajigaya S, Wise RJ, Liu JM, Youssoufian H: Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 91:4379, 1998
51. Kupfer GM, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea AD: The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 90:1047, 1997